To further verify the predictive power of GRB7 in ovarian cancer overall survival, we conducted univariate and multivariate regression analyses of GRB7 and clinicopathologic factors with OS in OC patients from TCGA and found that it may be an independent risk factor for ovarian cancer (Figure 2E). Here, GRB7 is linked to ovarian carcinoma.